Aquinox Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aquinox Pharmaceuticals Inc
TickerNGNE
CIK #0001404644
CUSIP64135M105
SectorLife Sciences - Pharmaceutical Preparations
Address887 Great Northern Way Suite 450, Vancouver, BC V5T 4T5
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Aquinox Pharmaceuticals USA Inc 2013-04-01 14.0 M Exemption: 506 · Remaining: $6,999,987 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001404644] 10-K
[0001404644] 10-Q
[0001404644] 3
[0001404644] 4
[0001404644] 5
[0001404644] 8-K
[0001404644] D
[0001404644] SC 13D
[0001404644] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Trails Edge Capital Partners LP Neurogene Inc [2025-12-15] 0.0
Baker Bros Advisors LP Neurogene Inc [2025-05-15] 0.0
Commodore Capital LP Neurogene Inc [2024-12-11] 5.4
RTW Investments LP Neurogene Inc [2024-11-14] 8.7
FMR LLC Neurogene Inc [2024-11-12] 0.0
Casdin Capital LLC Neurogene Inc [2024-11-08] 6.9
BlackRock Inc Neurogene Inc [2024-07-08] 10.7
Samsara Biocapital LP Neurogene Inc [2024-02-14] 0.99
Cormorant Asset Management LP Neurogene Inc [2024-02-14] 1.21
EcoR1 Capital LLC Neurogene Inc [2024-02-14] 0.99
Janus Henderson Group PLC Neurogene Inc [2024-02-14] 6.6
Great Point Partners LLC Neurogene Inc [2023-12-27] 7.56
McMinn Rachel Neurogene Inc [2023-12-21] 0.9
Redmile Group LLC Neoleukin Therapeutics Inc [2023-07-27] 6.6
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2023-02-03] 0.0
Lynx1 Capital Management LP Neoleukin Therapeutics Inc [2022-12-30] 5.38
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-19] 5.0
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-15] 4.97
BlackRock Inc Neoleukin Therapeutics Inc [2022-07-08] 2.1
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-07] 4.98
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2022-02-10] 6.07
Redmile Group LLC Neoleukin Therapeutics Inc [2021-02-16] 0.9
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2021-02-12] 6.96
ULGE UMUT Neoleukin Therapeutics Inc [2021-02-12] 6.98
BlackRock Inc Neoleukin Therapeutics Inc [2021-02-02] 6.4
ULGE UMUT Neoleukin Therapeutics Inc [2020-02-13] 8.2
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2020-02-13] 8.2
Drachman Jonathan G Neoleukin Therapeutics Inc [2019-12-27] 5.8
EcoR1 Capital LLC Neoleukin Therapeutics Inc [2019-12-27] 8.1
EcoR1 Capital LLC Aquinox Pharmaceuticals Inc [2018-07-16] 7.5
Price T Rowe Associates Inc /MD/ Aquinox Pharmaceuticals Inc [2016-10-11] 14.4
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2016-02-16] 5.93
BlackRock Inc Aquinox Pharmaceuticals Inc [2016-01-28] 5.3
Visium Asset Management LP Aquinox Pharmaceuticals Inc [2015-09-21] 8.6
RA Capital Management LLC Aquinox Pharmaceuticals Inc [2015-08-24] 0.6
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2015-08-10] 39.8
Augment Investments Ltd Aquinox Pharmaceuticals Inc [2015-02-12] 5.3
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2015-02-11] 14.1
Franklin Resources Inc Aquinox Pharmaceuticals Inc [2015-02-09] 5.5
Johnson & Johnson Aquinox Pharmaceuticals Inc [2015-02-06] 15.1
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2014-04-10] 12.1
Pfizer Inc Aquinox Pharmaceuticals Inc [2014-03-21] 9.0
Form 3/4/5 Filer 2011 - 2026
Aquinox Pharmaceuticals Inc
Cvijic Christine Mikail
Shafer Christina
Jordan Julie
McMinn Rachel
Cobb Stuart
Palekar Rohan
Noonberg Sarah B
Freedland Cory S
Baffi Robert
Woods Keith
Woods Robert Keith
Samsara BioCapital GP LLC
Akkaraju Srinivas
Samsara BioCapital LP
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Smith Sean Michael
Lavelle Erin
Simpson Todd E
Babler Martin
Patel Priti
Drachman Jonathan G
Cochener Donna
Walkey Carl
Ho Robert
Vance Holly
Williams Lewis T
Lavelle Erin M
Nolan Sean P
Redmile Group LLC
Green Jeremy
Boyd Meta Cantey
Main David
McCloskey Shelley
MacKenzie Lloyd
Alam Kamran
Levitt Daniel J
Bridger Gary
Pelzer Robert
Troupin Barbara
Jenkins Abigail
Neu Kelvin
Levy Richard S
Mitchell David Chilton
Shrewsbury Stephen B
Johnson & Johnson
Johnson & Johnson Development Corp ET AL
Pfizer Inc
Ventures West 8 Limited Partnership
Jones Elaine V
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Jordan Julie
Common Stock
2026-03-26 Sell 828 $21.89 18,125
Cvijic Christine Mikail
Common Stock
2026-03-26 Sell 2,558 $21.62 55,304
McMinn Rachel
Common Stock
2026-03-26 Sell 3,352 $22.07 73,979
Cvijic Christine Mikail
Common Stock
2026-03-13 Sell 263 $22.02 5,791
Cobb Stuart
Common Stock
2026-03-13 Sell 2,658 $21.34 56,722
Cobb Stuart
Common Stock
2026-03-13 Sell 148 $22.08 3,268
Cvijic Christine Mikail
Common Stock
2026-03-13 Sell 2,387 $20.42 48,743
Cobb Stuart
Common Stock
2026-03-13 Sell 3,991 $20.41 81,456
Cvijic Christine Mikail
Common Stock
2026-03-13 Sell 1,395 $21.25 29,644
Cvijic Christine Mikail
Common Stock
2026-02-27 Sell 4,800 $25.11 120,528
Cvijic Christine Mikail
Common Stock
2026-02-20 Grant 22,000 $0.00
Cobb Stuart
Common Stock
2026-02-20 Grant 16,500 $0.00
Freedland Cory S
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
McMinn Rachel
Common Stock
2026-02-20 Grant 25,900 $0.00
Noonberg Sarah B
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Cvijic Christine Mikail
Stock Option (Right to Buy) · derivative
2026-02-20 Grant 131,900 $0.00
Baffi Robert
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
McMinn Rachel
Stock Option (Right to Buy) · derivative
2026-02-20 Grant 155,100 $0.00
Palekar Rohan
Non-Qualified Stock Option (right to buy) · derivative
2026-02-20 Grant 12,050 $0.00
Jordan Julie
Common Stock
2026-02-20 Grant 4,900 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 98 17,173,316
2025-12-31 94 16,516,555
2025-09-30 89 15,340,810
2025-06-30 84 15,500,562
2025-03-31 88 16,786,255
2024-12-31 92 16,425,835
2024-09-30 87 13,852,246
2024-06-30 67 13,342,205
2024-03-31 61 13,162,728
2023-12-31 36 9,626,153
Form 13F Holdings
Firm Period DFND Voting Shares
Gamma Investing LLC [2026-06-30] DFND 545 545
Farther Finance Advisors LLC [2026-06-30] SOLE 0 176
Fortitude Family Office LLC [2026-06-30] SOLE 8 8
Hughes Financial Services LLC [2026-06-30] SOLE 2 2
IFP Advisors LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com